KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) EBITDA Margin (2016 - 2026)

Staar Surgical (STAA) has disclosed EBITDA Margin for 17 consecutive years, with 39.51% as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 1751.0% year-over-year to 39.51%, compared with a TTM value of 38.3% through Jan 2026, down 3429.0%, and an annual FY2026 reading of 38.3%, down 3429.0% over the prior year.
  • EBITDA Margin was 39.51% for Q1 2026 at Staar Surgical, down from 19.52% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 20.99% in Q3 2022 and bottomed at 134.78% in Q1 2025.
  • Average EBITDA Margin over 5 years is 12.1%, with a median of 5.73% recorded in 2022.
  • The sharpest move saw EBITDA Margin tumbled -141749bps in 2022, then soared 1751bps in 2026.
  • Year by year, EBITDA Margin stood at 5.05% in 2022, then tumbled by -376bps to 13.92% in 2023, then crashed by -310bps to 57.02% in 2024, then skyrocketed by 134bps to 19.52% in 2025, then crashed by -302bps to 39.51% in 2026.
  • Business Quant data shows EBITDA Margin for STAA at 39.51% in Q1 2026, 19.52% in Q3 2025, and 67.61% in Q2 2025.